tiprankstipranks
Trending News
More News >

Avalo Therapeutics Signs New Sales Agreement

Story Highlights
Avalo Therapeutics Signs New Sales Agreement

Confident Investing Starts Here:

An announcement from Avalo Therapeutics ( (AVTX) ) is now available.

On June 5, 2025, Avalo Therapeutics entered into a new Sales Agreement with TD Securities to offer and sell up to $75 million in common stock shares. This agreement follows the termination of a previous agreement with Oppenheimer & Co., which was concluded on June 4, 2025, allowing Avalo to explore new market opportunities without incurring termination penalties.

The most recent analyst rating on (AVTX) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Avalo Therapeutics stock, see the AVTX Stock Forecast page.

Spark’s Take on AVTX Stock

According to Spark, TipRanks’ AI Analyst, AVTX is a Neutral.

The overall score is driven by Avalo Therapeutics’ significant financial challenges and negative valuation metrics, which are partially offset by positive corporate developments, including strategic management changes and promising product potential. Technical indicators suggest a bearish trend.

To see Spark’s full report on AVTX stock, click here.

More about Avalo Therapeutics

Avalo Therapeutics, Inc. operates in the biotechnology industry, focusing on the development and commercialization of therapeutic solutions. The company primarily deals with the creation and sale of common stock shares as part of its financial strategies.

Average Trading Volume: 78,853

Technical Sentiment Signal: Strong Sell

Current Market Cap: $47.64M

Find detailed analytics on AVTX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App